Incyte Corp (INCY)
52.71
-0.51
(-0.96%)
USD |
NASDAQ |
Apr 17, 16:00
52.75
+0.04
(+0.08%)
After-Hours: 06:42
Incyte Market Cap: 11.83B for April 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 17, 2024 | 11.83B |
| April 16, 2024 | 11.95B |
| April 15, 2024 | 12.00B |
| April 12, 2024 | 12.09B |
| April 11, 2024 | 12.33B |
| April 10, 2024 | 12.35B |
| April 09, 2024 | 12.42B |
| April 08, 2024 | 12.36B |
| April 05, 2024 | 12.40B |
| April 04, 2024 | 12.35B |
| April 03, 2024 | 12.42B |
| April 02, 2024 | 12.54B |
| April 01, 2024 | 12.72B |
| March 28, 2024 | 12.79B |
| March 27, 2024 | 12.82B |
| March 26, 2024 | 12.70B |
| March 25, 2024 | 12.91B |
| March 22, 2024 | 12.79B |
| March 21, 2024 | 12.96B |
| March 20, 2024 | 13.08B |
| March 19, 2024 | 13.10B |
| March 18, 2024 | 12.87B |
| March 15, 2024 | 13.11B |
| March 14, 2024 | 13.14B |
| March 13, 2024 | 13.23B |
| Date | Value |
|---|---|
| March 12, 2024 | 13.32B |
| March 11, 2024 | 13.65B |
| March 08, 2024 | 13.48B |
| March 07, 2024 | 13.25B |
| March 06, 2024 | 13.31B |
| March 05, 2024 | 13.22B |
| March 04, 2024 | 13.41B |
| March 01, 2024 | 13.26B |
| February 29, 2024 | 13.10B |
| February 28, 2024 | 13.47B |
| February 27, 2024 | 13.70B |
| February 26, 2024 | 13.59B |
| February 23, 2024 | 13.60B |
| February 22, 2024 | 13.68B |
| February 21, 2024 | 13.55B |
| February 20, 2024 | 13.21B |
| February 16, 2024 | 13.01B |
| February 15, 2024 | 13.24B |
| February 14, 2024 | 13.00B |
| February 13, 2024 | 13.32B |
| February 12, 2024 | 12.99B |
| February 09, 2024 | 12.95B |
| February 08, 2024 | 12.88B |
| February 07, 2024 | 12.87B |
| February 06, 2024 | 13.39B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.69B
Minimum
Oct 30 2023
23.92B
Maximum
Jul 20 2020
16.86B
Average
16.86B
Median
Market Cap Benchmarks
| Novartis AG | 190.26B |
| MorphoSys AG | 2.713B |
| Illumina Inc | 18.80B |
| Biogen Inc | 27.92B |
| Exelixis Inc | 6.936B |
Market Cap Related Metrics
| PE Ratio | 19.89 |
| PS Ratio | 3.223 |
| PEG Ratio | 0.2676 |
| Price to Book Value | 2.280 |
| Price to Free Cash Flow | 26.53 |
| Price | 52.71 |
| Earnings Yield | 5.03% |
| PEGY Ratio | 0.2676 |
| Operating PE Ratio | 18.33 |
| Normalized PE Ratio | 20.24 |